High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis

M Kawashiri, C Maugeais, DJ Rader - Current atherosclerosis reports, 2000 - Springer
New therapeutic approaches to the prevention and treatment of atherosclerotic
cardiovascular disease (ASCVD) are needed. Plasma levels of high-density lipoprotein …

Interaction of DNA-binding proteins with the tissue-specific human apolipoprotein-AII enhancer

MA Lucero, D Sanchez, AR Ochoa… - Nucleic acids …, 1989 - academic.oup.com
The identification of the binding sites for liver nuclear proteins present in the enhancer that
control the cell specific transcription of the human apolipoprotein AII gene is reported. Five …

Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene

MJ Artiga, MJ Bullido, I Sastre, M Recuero… - FEBS …, 1998 - Wiley Online Library
In this work, we explored the existence of genetic variants within the apolipoprotein E gene
transcriptional regulatory region, using a denaturing gradient gel electrophoresis screening …

[HTML][HTML] The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution.

WH Li, M Tanimura, CC Luo, S Datta, L Chan - Journal of lipid research, 1988 - Elsevier
The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships,
and evolution. - ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & …

Regulation of human apolipoprotein B gene expression at multiple levels

AB Wang, DP Liu, CC Liang - Experimental cell research, 2003 - Elsevier
Apolipoprotein B is a large, amphipathic protein that plays a central role in lipoprotein
metabolism. Because its overproduction and deficiency leads to metabolic and pathologic …

Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor …

GS Ginsburg, J Ozer… - The Journal of clinical …, 1995 - Am Soc Clin Investig
We have used apolipoprotein genes to investigate the signal transduction mechanisms
involved in the control of intestinal specific gene expression. The human apoAI, apoCIII, and …

Transcription efficiency of human apolipoprotein AI promoter varies with naturally occurring A to G transition

R Tuteja, N Tuteja, C Melo, G Casari, FE Baralle - FEBS letters, 1992 - Elsevier
In human, the gene coding for apolipoprotein AI (apo AI), a protein of the plasma lipid
transport system, is expressed only in the liver and the intestine. A naturally occurring A to G …

A Phenotype-Sensitizing Apoe-Deficient Genetic Background Reveals Novel Atherosclerosis Predisposition Loci in the Mouse

HM Dansky, P Shu, M Donavan, J Montagno… - Genetics, 2002 - academic.oup.com
Therapeutic intervention for atherosclerosis has predominantly concentrated on regulating
cholesterol levels; however, these therapeutics are not efficacious for all patients …

The A/G polymorphism in the− 78 position of the apolipoprotein AI promoter does not have a direct effect on transcriptional efficiency

GM Danek, M Valenti, FE Baralle, M Romano - Biochimica et Biophysica …, 1998 - Elsevier
A promoter polymorphism A/G at position 78 bp upstream of the transcription initiation site
characterizes the human apolipoprotein AI gene. Some studies correlated the higher Apo AI …

Multiple tissue-specific elements control the apolipoprotein E/CI gene locus in transgenic mice

WS Simonet, N Bucay, RE Pitas, SJ Lauer… - Journal of Biological …, 1991 - ASBMB
To investigate the mechanisms controlling tissue-specific expression of the human
apolipoprotein (apo) E/CI gene locus, human apoE and apoC-I gene constructs containing …